St. Luke's International Hospital
Tokyo, 1048560, Japan
NCT Number: NCT06446076
This is a prospective, randomized controlled trial. The aim of the study is to verify the effectiveness of interventions using gamification with social incentives and social support to increase physical activity in patients with CVD through randomized controlled trials.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Tokyo, 1048560, Japan
The three aims of this randomized controlled trials;
Secondary Objective:
This trial will be a five-group, randomized controlled trial (RCT) with an intervention period of 6 weeks and a follow-up period of additional 6 weeks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will take part in a 6-week game-based program designed to help them reach their daily step goals. They are encouraged to maintain their daily step counts to achieve their daily step target over the 6-week intervention period. The gamification design incorporates two theoretically effective behavioral economics principles, "Fresh Start" and "Loss Aversion". All participants start from the Silver rank (middle rank), and their rank changes based on each final point of the week. The ranks are set from top to bottom as Platinum, Gold, Silver, Bronze, and Blue. In loss framing, if the daily step target is 6000 steps, maintaining 70 points for achieving 6000 steps on day 1, and a deduction of 10 points for not achieving it. In gain framing, achieving 6000 steps on day 1 results in an addition of 10 points, with no increase for not achieving it. After one week, ranks increase if the points at midnight on Sunday are 40 or above, and decrease if below this threshold.
Participants in this group are asked to designate a family member or friend to provide social support. This supporter is encouraged to check the participant's progress and provide support during the interventional period. The supporter will also receive weekly emails throughout the period, informing them about the participant's daily step counts, achievement status, points, levels, and other relevant information.
Time frame: From enrollment to the end of intervention period at 8 weeks (2-weeks run-in and 6-weeks intervention period)
The primary outcome is change in mean daily step counts from baseline to the 6-week intervention period.
Time frame: From enrollment to the end of follow-up period at 14 weeks
Secondary outcomes include the percentage of days achieving their step goals during the intervention and follow-up periods and the change in daily step counts from baseline to follow-up period.
Time frame: From enrollment to the end of follow-up period at 14 weeks
Change in the participant's subjective assessment of physical activity level measured using the International Physical Activity Questionnaire (IPAQ) Short Form. This is a survey that investigates how individuals engage in physical activity (how they move their bodies) in their daily lives. It is a questionnaire that assesses the duration and frequency of exercise based on intensity levels.
Time frame: From enrollment to the end of follow-up period at 14 weeks
Change in body weight (BMI) (kg/m^2)
Time frame: From enrollment to the end of follow-up period at 14 weeks
Change in LDL/HDL cholesterol (mg/dL)
St. Luke's International Hospital, Japan
Other
Feedback Using behaviOral econOmic Theories on STEP countS in Cardiovascular Disease Patients: A Randomized Controlled Trial
Acronym: FOOTSTEPS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06396793
Anxiety, Anxiety Disorders
Milan, MI, Italy
View Trial DetailsNCT06302634
Behavior, Cardio-oncology
Santiago de Compostela, A Coruña, Spain
View Trial DetailsNCT04872153
Basal Ganglia Diseases, Brain Diseases
Dussnang, Thurgau, Switzerland
View Trial DetailsNCT04617834
Acute Coronary Syndrome, Cardiovascular Diseases
Wilkesboro, North Carolina, United States
View Trial Details